Canada markets closed
  • S&P/TSX

    17,909.03
    -49.06 (-0.27%)
     
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • DOW

    30,814.26
    -177.26 (-0.57%)
     
  • CAD/USD

    0.7857
    -0.0054 (-0.68%)
     
  • CRUDE OIL

    52.04
    -1.53 (-2.86%)
     
  • BTC-CAD

    45,761.52
    +83.27 (+0.18%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • GOLD FUTURES

    1,827.70
    -23.70 (-1.28%)
     
  • RUSSELL 2000

    2,123.20
    -32.15 (-1.49%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • NASDAQ

    12,998.50
    -114.14 (-0.87%)
     
  • VOLATILITY

    24.34
    +1.09 (+4.69%)
     
  • FTSE

    6,735.71
    -66.25 (-0.97%)
     
  • NIKKEI 225

    28,519.18
    -179.08 (-0.62%)
     
  • CAD/EUR

    0.6500
    -0.0004 (-0.06%)
     

What the papers say – November 24

By PA
·3 min read

The coronavirus continues to make headlines, with the new tiered plan dominating the papers along with details of the latest Oxford/AstraZeneca vaccine trial.

The Times suggests that restrictions could start to wind down in Easter after reports the Oxford vaccine was “highly effective”.

The Daily Telegraph features a quote from Prime Minister Boris Johnson, who said it was the season “to be jolly careful” as he announced new restrictions starting in December, a line which also leads Metro and the Daily Express.

While The Guardian says the world is a step closer to normality after the success of the Oxford vaccine trials, with the Financial Times reporting they add to the “armoury” in the battle against Covid.

The i reports the new tier rules will finish in spring as Downing Street warned of “cold, hard months ahead”. The Independent carries a similar line, quoting Mr Johnson as saying an “escape route” was in sight.

The Daily Mirror says the vaccine brings a “fresh hope”, while the Daily Mail says the Oxford jab could be rolled out “in weeks”.

The Sun claims that contestants on I’m A Celebrity get a “secret run-through” of trials.

And the Daily Star reports on developments in the case of Jeremy Kyle guest Steve Dymond.